NewAmsterdam Pharma
(NASDAQ) NAMS
NewAmsterdam Pharma Financials at a Glance
Market Cap
$3.71B
Revenue (TTM)
$22.57M
Net Income (TTM)
-$212.73M
EPS (TTM)
-$1.80
P/E Ratio
-17.58
Dividend
$0.00
Beta (Volatility)
0.52 (Low)
Dividend
$0.00
Beta (Volatility)
0.52 (Low)
Price
$33.13
Volume
52,205
Open
$31.93
Price
$33.13
Volume
52,205
Open
$31.93
Previous Close
$33.13
Daily Range
$31.93 - $33.33
52-Week Range
$17.97 - $42.21
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
0.52 (Low)
Price
$33.13
Volume
52,205
Open
$31.93
Previous Close
$33.13
Daily Range
$31.93 - $33.33
52-Week Range
$17.97 - $42.21
Estimated Earnings Date
Aug 5, 2026
NAMS News
NAMS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NewAmsterdam Pharma
Industry
Biotechnology
Sector
Health CareEmployees
100
CEO
Michael H. Davidson, MD
Website
www.newamsterdampharma.comHeadquarters
Naarden, NH 1411 DC, NL
NAMS Financials
Key Financial Metrics (TTM)
Gross Margin
97.52%
Operating Margin
-953.59%
Net Income Margin
-942.76%
Return on Equity
-29.80%
Return on Capital
-33.01%
Return on Assets
-29.04%
Earnings Yield
-5.69%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.71B
Shares Outstanding
116.90M
Volume
52.20K
Avg. Volume
1.26M
Financials (TTM)
Gross Profit
$22.01M
Operating Income
-$215.18M
EBITDA
-$212.50M
Operating Cash Flow
-$141.92M
Capital Expenditure
-$268.00K
Free Cash Flow
-$142.19M
Cash & ST Invst.
$636.11M
Total Debt
$23.00K
NewAmsterdam Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.04M
+2.1%
Gross Profit
$2.54M
-14.7%
Gross Margin
83.55%
N/A
Market Cap
$3.71B
N/A
Market Cap/Employee
$37.09M
N/A
Employees
100
N/A
Net Income
-$48.44M
-22.6%
EBITDA
-$48.38M
-22.6%
Quarterly Fundamentals
Total Cash
$636.11M
-21.3%
Total Debt
$23.00K
-94.1%
Accounts Receivable
$8.22M
+409.7%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$23.00K
-90.9%
Return on Assets
-29.04%
N/A
Return on Invested Capital
-32.35%
N/A
Free Cash Flow
-$30.64M
+16.0%
Operating Cash Flow
-$30.60M
+16.1%